Answers are grounded in this paper and cite their sources.
Lagerstroemia speciosa (Lythraceae), commonly known as banaba, is a plant native to thetropical regions of Southeast Asia that thrives abundantly in Vietnam and has been historicallyutilized in traditional medicine. Despite evidence suggesting that its leaves have anti-diabeticproperties, studies investigating the effects of L. speciosa extracts on animal models of type 2diabetes remain limited. Herein, the effect of dry extract from L. speciosa leaves (VLDE)collected in Vietnam on blood glucose in type 2 diabetic rats was evaluated. White rats weredivided into five groups, each comprising 10 rats. Group 1 served as the non-diabetic control,receiving distilled water, while type 2 diabetes was induced in other groups with a high-fat dietand low-dose streptozotocin. Group 3 received gliclazide at a dose of 20 mg/kg/day as thepositive control, whereas groups 4 and 5 were administered VLDE at doses of 620 mg/kg/dayand 1240 mg/kg/day, respectively, for a treatment duration of 28 days. Blood glucose levels,blood insulin levels, and insulin resistance indices were evaluated pre-and post-treatment. VLDEat both doses demonstrated significant blood glucose-lowering effects, accompanied by areduction in the HOMA-IR index and elevation in the HOMA-β, QUICKI, and DI indices, aswell as an increase in the pancreatic mass-to-body weight ratio, comparable to the gliclazidetreated group. Our findings underscore the potential of L. speciosa extract as a medicinaltherapeutic agent for type 2 diabetes management, warranting further pre-clinical and clinicalvalidation for pharmaceutical development.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: